102 related articles for article (PubMed ID: 6821292)
1. [Ataxia in rolling mouse Nagoya and the norepinephrine system--a psychopharmacological study].
Matsui K; Toyoshima E; Mano U; Ando K
Yakubutsu Seishin Kodo; 1982 Dec; 2(2):77-80. PubMed ID: 6821292
[TBL] [Abstract][Full Text] [Related]
2. [Noradrenaline metabolism in the brain of rolling mouse Nagoya and the influence of thyrotropin releasing hormone (author's transl)].
Konagaya M; Takayanagi T; Muroga T; Adachi K; Sobue I
Rinsho Shinkeigaku; 1980 Mar; 20(3):181-8. PubMed ID: 6103773
[No Abstract] [Full Text] [Related]
3. Alterations in local cerebral glucose metabolism and endogenous thyrotropin-releasing hormone levels in rolling mouse Nagoya and effect of thyrotropin-releasing hormone tartrate.
Nakayama T; Nagai Y
Jpn J Pharmacol; 1996 Nov; 72(3):241-6. PubMed ID: 8957685
[TBL] [Abstract][Full Text] [Related]
4. [The antiataxic mechanism of TRH in rolling mouse Nagoya: the effects of pretreatment with dopaminergic and cholinergic drugs].
Matsui K; Ando K
Jikken Dobutsu; 1984 Oct; 33(4):465-9. PubMed ID: 6440800
[TBL] [Abstract][Full Text] [Related]
5. Studies on thyrotropin releasing hormone in cerebellar ataxia mutant mouse brain.
Fukuma N; Nihei N
Life Sci; 1986 May; 38(18):1625-31. PubMed ID: 2871469
[TBL] [Abstract][Full Text] [Related]
6. Serotonergic regulation of the spinal cord content of thyrotropin releasing hormone in the cerebellar ataxia mutant mouse.
Endo S; Itoh M; Serizawa O
J Neurol Sci; 1993 Sep; 118(2):194-201. PubMed ID: 8229069
[TBL] [Abstract][Full Text] [Related]
7. The pharmacological effect of thyrotropin-releasing hormone on ataxic mutant mice.
Mano Y; Matsui K; Toyoshima E; Ando K
Acta Neurol Scand; 1986 Apr; 73(4):352-8. PubMed ID: 3088901
[TBL] [Abstract][Full Text] [Related]
8. Distribution of thyrotropin-releasing hormone (TRH) receptors in the brain of the ataxic mutant mouse, rolling mouse Nagoya.
Kinoshita K; Yamamura M; Sugihara J
Biol Pharm Bull; 1997 Jan; 20(1):86-7. PubMed ID: 9013814
[TBL] [Abstract][Full Text] [Related]
9. Regional difference in corticotropin-releasing factor immunoreactivity in mossy fiber terminals innervating calretinin-immunoreactive unipolar brush cells in vestibulocerebellum of rolling mouse Nagoya.
Ando M; Sawada K; Sakata-Haga H; Jeong YG; Takeda N; Fukui Y
Brain Res; 2005 Nov; 1063(1):96-101. PubMed ID: 16256961
[TBL] [Abstract][Full Text] [Related]
10. [Effect of DN-1417 on ataxia in Rolling mouse Nagoya and Staggerer mouse in comparison with the effect of TRH].
Matsui K; Mano Y; Ando K
Yakubutsu Seishin Kodo; 1986 Jun; 6(2):281-3. PubMed ID: 3096012
[TBL] [Abstract][Full Text] [Related]
11. Anti-ataxic effects of TRH and its analogue, TA-0910, in Rolling mouse Nagoya by metabolic normalization of the ventral tegmental area.
Kinoshita K; Watanabe Y; Asai H; Yamamura M; Matsuoka Y
Br J Pharmacol; 1995 Dec; 116(8):3274-8. PubMed ID: 8719807
[TBL] [Abstract][Full Text] [Related]
12. Effects of TA-0910, a novel orally active thyrotropin-releasing hormone analog, on the gait of ataxic animals.
Kinoshita K; Fujitsuka T; Yamamura M; Matsuoka Y
Eur J Pharmacol; 1995 Feb; 274(1-3):65-72. PubMed ID: 7768282
[TBL] [Abstract][Full Text] [Related]
13. Chronic anti-ataxic actions of the novel thyrotropin-releasing hormone (TRH) analog, TA-0910, during and after repeated administration in Rolling mouse Nagoya: behavioral and pharmacokinetic studies.
Kinoshita K; Fukushima T; Kodama Y; Sugihara J; Yamamura M; Matsuoka Y
Biol Pharm Bull; 1997 Jan; 20(1):36-9. PubMed ID: 9013803
[TBL] [Abstract][Full Text] [Related]
14. [New connection of hypothalamic hormone and the function of CNS...with special reference to relationship between TRH and ataxia (author's transl)].
Sobue E
Rinsho Shinkeigaku; 1977 Dec; 17(12):791-9. PubMed ID: 204434
[No Abstract] [Full Text] [Related]
15. Ameliorating effect of rovatirelin on the ataxia in rolling mouse Nagoya.
Ijiro T; Yaguchi A; Yokoyama A; Abe Y; Kiguchi S
Eur J Pharmacol; 2020 Sep; 882():173271. PubMed ID: 32534077
[TBL] [Abstract][Full Text] [Related]
16. Effects of thyrotropin releasing hormone on cerebellar mutant mice--a kinesiological comparison between rolling mouse Nagoya, weaver and reeler.
Muroga T; Adachi K; Konagaya M; Takayanagi T; Sobue I
Jpn J Med; 1982 Apr; 21(2):101-8. PubMed ID: 6811784
[TBL] [Abstract][Full Text] [Related]
17. Differential alterations in expressions of ryanodine receptor subtypes in cerebellar cortical neurons of an ataxic mutant, rolling mouse Nagoya.
Sawada K; Hosoi E; Bando M; Sakata-Haga H; Lee NS; Jeong YG; Fukui Y
Neuroscience; 2008 Mar; 152(3):609-17. PubMed ID: 18313230
[TBL] [Abstract][Full Text] [Related]
18. Studies on the central action of L-threo-3,4-dihydroxyphenyl-serine (L-threo-DOPS) in FLA-63-treated mice.
Kato T; Katsuyama M; Karai N; Nakamura M; Katsube J
Pharmacol Biochem Behav; 1987 Feb; 26(2):407-11. PubMed ID: 3106991
[TBL] [Abstract][Full Text] [Related]
19. Neurotransmitter abnormality in Rolling mouse Nagoya, an ataxic mutant mouse.
Muramoto O; Kanazawa I; Ando K
Brain Res; 1981 Jun; 215(1-2):295-304. PubMed ID: 6167317
[TBL] [Abstract][Full Text] [Related]
20. [Histydyl-proline diketopiperazine (HPD), a metabolite of thyrotropin-releasing hormone (TRH), improves the ataxic gait in 3-acetylpyridine (3-AP) treated rats].
Kurahashi K; Kannari K; Kimura K; Matsunaga M; Takebe K
No To Shinkei; 1986 Sep; 38(9):893-8. PubMed ID: 3790371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
